Knowing When to Seek Urgent Care: Emergencies and Red Flags
At a Glance
In mast cell leukemia, trouble breathing, facial swelling, fainting, severe bleeding, sudden confusion or weakness, and signs of serious infection require urgent medical help. Use prescribed epinephrine immediately for a severe allergic reaction and follow your oncology team's fever plan.
Living with Mast Cell Leukemia (MCL) requires a shift in how you monitor your health. Because this disease is aggressive and affects your blood’s ability to clot and fight infection, you must be prepared for situations that require immediate medical intervention. However, it is equally important to know when a symptom is a part of the “routine” of the disease so you do not live in a constant state of alarm.
Symptoms to Discuss with Your Team (Not Always 911 Emergencies)
Some symptoms may be manageable at home only if they are stable and have already been discussed with your team. However, new, rapidly worsening, severe, or unexplained symptoms require an urgent call. These typically include:
- Stable Fatigue: Feeling very tired can relate to anemia or other causes [1][2].
- Mild Skin Flushing or Itching: These are common “mediator” symptoms in mast cell disorders and are usually managed with daily antihistamines [3][4].
- Chronic, Mild Bone Pain: Often caused by mast cells infiltrating the bones, this is typically handled with your regular pain management plan [1].
- Predictable Treatment Side Effects: Mild nausea or minor diarrhea after taking medications like midostaurin or avapritinib is common [5][2].
Emergency Red Flags: Call 911 or Go to the ER
In MCL, certain symptoms represent life-threatening complications like anaphylaxis, severe bleeding, or sepsis (a systemic reaction to infection).
1. Anaphylaxis (Severe Allergic Reaction)
Because your body has an overabundance of mast cells, they can release a massive wave of chemicals all at once. If prescribed, use your epinephrine auto-injector immediately and call emergency services if you experience:
- Sudden difficulty breathing or “tightness” in the throat [6].
- Swelling of the face, lips, or tongue [6].
- A sudden drop in blood pressure, feeling faint, or passing out [7][8].
- Rapidly progressing abdominal pain, vomiting, or diarrhea [6].
Action: Epinephrine is the only first-line treatment for anaphylaxis. Do not wait to see if an antihistamine works; use the auto-injector in the outer thigh immediately [9][10].
2. Severe or Internal Bleeding
MCL often causes thrombocytopenia (dangerously low platelets), which are the cells that stop bleeding. This risk is higher if you are taking the drug avapritinib, which has been linked to intracranial hemorrhage (bleeding in the brain) [11][12]. Your treating team will give you exact platelet thresholds to hold or adjust doses based on the product label. Do not start, continue, hold, or restart based on this guide. Avapritinib can also cause cognitive effects and fluid retention (edema).
- Brain Bleeding Signs: Sudden, “worst-ever” headache, confusion, seizures, weakness on one side of the body, or vision changes [11].
- Internal Bleeding Signs: Vomiting blood (may look like coffee grounds) or passing black, tarry, or bloody stools [13][14].
- Uncontrolled Bleeding: A nosebleed or cut that does not stop after 10–15 minutes of firm pressure.
3. Sepsis and Infection
When your white blood cell count is very low (neutropenia), your body cannot fight bacteria. A simple infection can turn into life-threatening sepsis in hours [13][8].
- Fever: Follow your individualized fever plan. Generally, a temperature over 100.4°F (38°C) requires immediate contact with your oncology team and urgent evaluation when neutropenia is present, but does not automatically mean calling 911 for every patient [13].
- Sepsis Signs: Shaking chills (rigors), confusion, extreme shivering, or feeling “colder than usual” while having a fever [13][15].
Same-Day Urgent Calls: Contact Your Clinic
If you notice these changes, call your hematology team the same day. They may need to adjust your medications or order a “stat” blood test.
- New Bruising or Petechiae: Petechiae are tiny, pinpoint red or purple spots on the skin that look like a rash but don’t blanch when pressed. They can be a sign of very low platelets [13].
- Increased Dizziness: This may mean your anemia has worsened or indicate another issue requiring a prompt call [1][2].
- New Swelling: Significant new swelling around the eyes (periorbital edema) or in the legs, which can be a side effect of certain TKIs [12].
Practical Safety Measures
- The Rule of Two: If prescribed, always carry two epinephrine auto-injectors. Follow your individualized Anaphylaxis Action Plan, which may advise a second dose if symptoms persist or worsen [9][16].
- Know Your Counts: Ask your doctor for your most recent platelet and neutrophil counts after every blood draw. Knowing your “baseline” helps you understand your specific level of risk [12][2].
- Medication Awareness: Ask your treating team before starting or stopping over-the-counter NSAIDs (like aspirin or ibuprofen), as they can further increase your risk of bleeding when your platelets are already low [11].
Common questions in this guide
Which mast cell leukemia symptoms mean I should call 911?
What should I do if I think I am having anaphylaxis with MCL?
When does a fever require urgent attention during mast cell leukemia treatment?
How do I recognize dangerous bleeding when my platelet count is low?
Which changes should prompt a same-day call to my hematology team?
Which blood counts should I track with mast cell leukemia?
Get notified when new evidence is published on Mast cell leukemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Case report: Experience of a rare case of primary acute mast cell leukemia.
Pan Z, Zhang Y, Guo Y, et al.
Leukemia research reports 2025; (23()):100510 doi:10.1016/j.lrr.2025.100510.
PMID: 40673268 - 2
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
Gotlib J, Kluin-Nelemans HC, George TI, et al.
The New England journal of medicine 2016; (374(26)):2530-41 doi:10.1056/NEJMoa1513098.
PMID: 27355533 - 3
Non-hematologic diagnosis of systemic mastocytosis: Collaboration of radiology and pathology.
Ozturk K, Cayci Z, Gotlib J, et al.
Blood reviews 2021; (45()):100693 doi:10.1016/j.blre.2020.100693.
PMID: 32334853 - 4
Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach.
Lee E, Picard M
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (21(1)):49 doi:10.1186/s13223-025-00998-9.
PMID: 41272881 - 5
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
Kasamon YL, Ko CW, Subramaniam S, et al.
The oncologist 2018; (23(12)):1511-1519 doi:10.1634/theoncologist.2018-0222.
PMID: 30115735 - 6
Acute abdomen due to anaphylactic intestinal edema associated with systematic mastocytosis: a case report.
Takagishi T, Miki K, Imashuku S, Takagishi K
International journal of emergency medicine 2022; (15(1)):38 doi:10.1186/s12245-022-00441-5.
PMID: 36002825 - 7
Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P, Bonifacio M, Lombardo C, Zanotti R
Current allergy and asthma reports 2016; (16(1)):5 doi:10.1007/s11882-015-0582-5.
PMID: 26714690 - 8
Case Report: Experience of a rare case of primary acute mast cell leukemia with FGFR1 gene rearrangement.
Liu Y, Gao S, Du H, et al.
Frontiers in oncology 2026; (16()):1830652 doi:10.3389/fonc.2026.1830652.
PMID: 42180116 - 9
Diagnosis and management of anaphylaxis.
Hearrell M, Anagnostou A
Journal of food allergy 2020; (2(1)):64-68 doi:10.2500/jfa.2020.2.200001.
PMID: 39022137 - 10
How to manage anaphylaxis in primary care.
Alvarez-Perea A, Tanno LK, Baeza ML
Clinical and translational allergy 2017; (7()):45 doi:10.1186/s13601-017-0182-7.
PMID: 29238519 - 11
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
DeAngelo DJ, Radia DH, George TI, et al.
Nature medicine 2021; (27(12)):2183-2191 doi:10.1038/s41591-021-01538-9.
PMID: 34873347 - 12
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.
Gotlib J, Reiter A, Radia DH, et al.
Nature medicine 2021; (27(12)):2192-2199 doi:10.1038/s41591-021-01539-8.
PMID: 34873345 - 13
Case Report: aleukemic mast cell leukemia with KIT p.V559G mutation, CD25-negative immunophenotype, and complex karyotype.
Zhang L, Jiang L, Zhang X, et al.
Frontiers in oncology 2026; (16()):1878036 doi:10.3389/fonc.2026.1878036.
PMID: 42488121 - 14
Systemic Mastocytosis Presenting as Non-cirrhotic Portal Hypertension With Upper Gastrointestinal Bleeding in a Young Female Patient: A Case Report.
Jangid A, Pandey P, Siddiqui MSI, et al.
Cureus 2026; (18(5)):e109267 doi:10.7759/cureus.109267.
PMID: 42326297 - 15
Necrotizing Fasciitis by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli as the Initial Presentation of Hairy Cell Leukemia: A Case Report.
Pérez-Valdez D, Sánchez-Rosado RR, Ortiz-Pacheco LJ, et al.
Cureus 2025; (17(7)):e88614 doi:10.7759/cureus.88614.
PMID: 40861689 - 16
Idiopathic Anaphylaxis.
Nwaru BI, Dhami S, Sheikh A
Current treatment options in allergy 2017; (4(3)):312-319 doi:10.1007/s40521-017-0136-2.
PMID: 28890861
This page is for informational purposes only and does not constitute medical advice or replace your personalized emergency, fever, or anaphylaxis plan. Follow your hematology team's instructions and call emergency services for life-threatening symptoms.